By Dave Muoio | MobiHealthNews | February 02, 2018
Optra Health, which produces AI-driven iPhronesis analysis platform for healthcare and life sciences clients, today announced the launch of a new genetics-focused product specially designed for consumers, genetic counselors, and other genomics researchers. The OptraGURU platform combines the AI tech of iPhronesis with the language capabilities of Amazon’s Alexa. Users can speak directly to OptraGURU to navigate through extensive genomic datasets or receive personalized insights.
“The convergence of artificial intelligence, conversational technologies like Alexa, and an ever-increasing availability of data is having a transformative effect on how research and clinical results are delivered and communicated,” Optra Health cofounder and CEO Gauri Naik said in a statement. “The possibilities of using OptraGURU and AI platforms like iPhronesis in combination with extensive public and private data sets, will advance research and improve the consumer experience.”